FDA approves Soliris for patients aged 6 years and up with generalized myasthenia gravis

Retrieved on: 2025-03-12 17:56:11

Tags for this article:

Click the tags to see associated articles and topics

FDA approves Soliris for patients aged 6 years and up with generalized myasthenia gravis. View article details on hiswai:

Excerpt

The FDA has approved an expanded indication of Soliris, an IV-administered monoclonal antibody for patients aged 6 years and older with ...

Article found on: www.healio.com